Real-time Estimate
Cboe BZX
12:47:45 2024-05-02 pm EDT
5-day change
1st Jan Change
1.135
USD
+0.44%
-2.13%
-41.33%
Presentation Operator MessageOperator (Operator)Good afternoon, and welcome, everyone, to the ...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Truist Lowers Price Target on Beyond Air to $8 From $10, Keeps Buy Rating
Apr. 30
MT
Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Feb. 12
CI
Beyond Air, Inc. Provides Revenue Guidance for the Fiscal Year 2025
Feb. 12
CI
Transcript : Beyond Air, Inc., Q3 2024 Earnings Call, Feb 12, 2024
Feb. 12
Earnings Flash (XAIR) BEYOND AIR Posts Q3 Revenue $391,000, vs. Street Est of $0.45M
Feb. 12
MT
North American Morning Briefing : Stock Futures Steady as Traders Await CPI Data
Feb. 12
DJ
Beyond Air Affiliate Says First Group Cleared in Phase 1 UNO Study in Solid Tumors; Shares Rise
Dec. 27
MT
Beyond Air Insider Bought Shares Worth $1,962,000, According to a Recent SEC Filing
Dec. 19
MT
Truist Cuts Beyond Air's Price Target to $10 From $14, Maintains Buy Rating
Nov. 14
MT
Beyond Air, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Nov. 13
CI
Transcript : Beyond Air, Inc., Q2 2024 Earnings Call, Nov 13, 2023
Nov. 13
Earnings Flash (XAIR) BEYOND AIR Reports Q2 Revenue $239,000, vs. Street Est of $482,000
Nov. 13
MT
Beyond Air, Inc. Provides Revenue Guidance for the Fiscal Year Ending March 31, 2025
Nov. 13
CI
Beyond Air, Inc. Receives Innovative Technology Contract from Vizient for LungFit PH
23-10-16
CI
EARNINGS: Andrews Sykes revenue up; Safestay optimistic
23-09-26
AN
Beyond Air, Inc. Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder
23-09-18
CI
Beyond Air, Inc. and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region
23-09-07
CI
Insider Buy: Beyond Air
23-08-29
MT
Beyond Air Files Shelf on Behalf of Selling Stockholders
23-08-14
MT
Beyond Air, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
23-08-10
CI
Transcript : Beyond Air, Inc., Q1 2024 Earnings Call, Aug 10, 2023
23-08-10
Earnings Flash (XAIR) BEYOND AIR Posts Q1 Revenue $59,000, vs. Street Est of $0.34M
23-08-10
MT
Beyond Air Says Preclinical Data Showed Potential of Nitric Oxide in Autism Spectrum Disorder Treatment
23-08-08
MT
Beyond Air, Inc. Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder
23-08-07
CI
Piper Sandler Starts Beyond Air at Overweight With $10 Price Target
23-07-28
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. The Companyâs LungFit platform can be used to treat patients on ventilators that require NO, as well as patients with chronic or acute severe lung infections through delivery through a breathing mask or similar apparatus. The Companyâs areas of focus with LungFit are persistent pulmonary hypertension of the newborn (PPHN), viral community-acquired pneumonia (VCAP), including COVID-19, bronchiolitis (BRO), nontuberculous mycobacteria (NTM) lung infection and various severe lung infections with underlying chronic obstructive pulmonary disease (COPD). Its LungFit PH is an ionizer technology that generates on-demand NO from ambient air and, regardless of dose or flow, delivers it to a ventilator circuit. The LungFit can generate up to 400 parts per million (ppm) of NO.
More about the company
Last Close Price
1.13
USD
Average target price
12.6
USD
Spread / Average Target
+1,015.04%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1